BeiGene is a global oncology company dedicated to discovering and developing innovative cancer treatments that are accessible and affordable for patients worldwide. Through a robust portfolio and a diverse pipeline of novel therapeutics, BeiGene strives to improve access to medicines and expedite the development of life-saving therapies.